The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Morbidity Profiles of Centenarians: Survivors, Delayers, and Escapers
Abstract
BACKGROUND: The compression of morbidity hypothesis predicts that, in order to achieve their extreme old age, centenarians markedly delay or even escape diseases that would otherwise be lethal at younger ages. Phenotypic studies have not adequately characterized the prevalence and timing of age-related illnesses among those who achieve exceptional old age. Thus, we conducted a retrospective cohort study of centenarians to explore the timing of such diseases among centenarians. METHODS: Health history questionnaires were completed by 424 centenarians (aged 97-119 years) or their proxies. Lifetime (to-date) diagnoses of 10 major lethal illnesses (hypertension, heart disease, diabetes, stroke, nonskin cancer, skin cancer, osteoporosis, thyroid condition, Parkinson's disease, and chronic obstructive pulmonary disease) and one ocular disease (cataracts) that befall the elderly population, approximate age of diagnosis, level of alcohol and tobacco use, and presence or absence of cognitive impairment were assessed. Because of the retrospective nature of the study, the typically imprecise age of onset of cognitive impairment negated the ability to include age of onset of cognitive impairment in this aspect of the analyses. RESULTS: Examining the ages of onset for the 10 age-associated diseases and excluding cognitive impairment, we found that the centenarians fit into three morbidity profiles-Survivors, Delayers, and Escapers. 24% of male subjects and 43% of female subjects fit the Survivor profile, or those who had a diagnosis of an age-associated illness prior to the age of 80. Delayers were individuals who delayed the onset of age-associated illness until at least the age of 80, and 44% of male and 42% of female subjects fit this profile. Escapers were individuals who attained their 100th year of life without the diagnosis of common age-associated illnesses, and 32% of male and 15% of female subjects fit the Escaper profile. When examining only the most lethal diseases of the elderly population, heart disease, nonskin cancer, and stroke, we found that 87% of male and 83% of female subjects delayed or escaped these diseases. Subjects with and without cognitive impairment did not differ in terms of the profile to which they belonged. CONCLUSIONS: These results suggest there may be multiple routes to achieving exceptional longevity and that there are sex differences according to which route is taken. These routes represent different phenotypes and thus likely different genotypes of centenarians. The identification of three types of centenarians, Survivors, Delayers, and Escapers, provides direction for future study into the factors that determine exceptional longevity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kriegsman, D. M. W., Penninx, B. W. J. H., Van Eijk, J. T. M., Boeke, A. J. P., & Deeg, D. J. H. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00274-0 · Cited by 939
The immunology of exceptional individuals: the lesson of centenarians
Franceschi, C., Monti, D., Sansoni, P., & Cossarizza, A. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80064-6 · Cited by 531
Aging, Health Risks, and Cumulative Disability
(1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390716 · Cited by 508
Aging, Health Risks, and Cumulative Disability
Vita, A. J., Terry, R. B., Hubert, H. B., & Fries, J. F. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381506 · Cited by 493
Seshadri, S., Wolf, P. A., Beiser, A., Au, R., McNulty, K., White, R., & D'Agostino, R. B. (1997) · Neurology · doi:10.1212/wnl.49.6.1498 · Cited by 489
Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging
Kawas, C., Gray, S., Brookmeyer, R., Fozard, J., & Zonderman, A. (2000) · Neurology · doi:10.1212/wnl.54.11.2072 · Cited by 472
Comparing self-reported and physician-reported medical history
Kehoe, R., Wu, S.-Y., Leske, M. C., & Chylack, L. T. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117078 · Cited by 441
Haapanen, N., Miilunpalo, S., Pasanen, M., Oja, P., & Vuori, I. (1997) · American Journal of Epidemiology · doi:10.1093/aje/145.8.762 · Cited by 418
Life-long sustained mortality advantage of siblings of centenarians
Perls, T. T., Wilmoth, J., Levenson, R., Drinkwater, M., Cohen, M., Bogan, H., Joyce, E., Brewster, S., Kunkel, L., & Puca, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122587599 · Cited by 382
Self-citationEffros, R. B., Boucher, N., Porter, V., Zhu, X., Spaulding, C., Walford, R. L., Kronenberg, M., Cohen, D., & Schächter, F. (1994) · Experimental Gerontology · doi:10.1016/0531-5565(94)90073-6 · Cited by 377
Cited by
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087
Depp, C. A., & Jeste, D. V. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000192501.03069.bc · Cited by 1,292
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“Evidence from centenarian and nonagenarian studies suggests that these oldest members of populations have had the ability to delay aging and age-related disease (385, 386).”
BackgroundFOXO3A genotype is strongly associated with human longevity
Willcox, B. J., Donlon, T. A., He, Q., Chen, R., Grove, J. S., Yano, K., Masaki, K. H., Willcox, D. C., Rodriguez, B., & Curb, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801030105 · Cited by 983
Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?
Santoro, A., Bientinesi, E., & Monti, D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101422 · Cited by 603
Genetic signatures of exceptional longevity in humans
Sebastiani, P., Solovieff, N., DeWan, A. T., Walsh, K. M., Puca, A., Hartley, S. W., Melista, E., Andersen, S., Dworkis, D. A., Wilk, J. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029848 · Cited by 464
“The NECS previously showed that centenarians fall into different groups in terms of age of onset of age-related diseases: survivors (onset of aging disease #80 years), delayers (onset of aging disease between 80 and 100 years) and escapers (age of onset $100 years) [67].”
Self-citationGenetics of healthy aging and longevity
Brooks-Wilson, A. R. (2013) · Human Genetics · doi:10.1007/s00439-013-1342-z · Cited by 380
“…al. 2006); the authors speculate based in part on absence of many age-related diseases from Okinawan (Bernstein et al. 2004) and other centenarians (Evert et al. 2003), that these individuals have genetic factors that confer resistance to such diseases and increase the likelihood of reaching…”
BackgroundMelzer, D., Pilling, L. C., & Ferrucci, L. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0183-6 · Cited by 363
Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians
Hashimoto, K., Kouno, T., Ikawa, T., Hayatsu, N., Miyajima, Y., Yabukami, H., Terooatea, T., Sasaki, T., Suzuki, T., Valentine, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907883116 · Cited by 343
“J Gerontol A Biol Sci Med Sci 69(4):486463 494.”
BackgroundThe Cambridge Handbook of Age and Ageing
(2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511610714 · Cited by 336
Andersen, S. L., Sebastiani, P., Dworkis, D. A., Feldman, L., & Perls, T. T. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr223 · Cited by 331
Self-citationDecreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring
Horvath, S., Pirazzini, C., Bacalini, M. G., Gentilini, D., Di Blasio, A. M., Delledonne, M., Mari, D., Arosio, B., Monti, D., Passarino, G., et al. (2015) · Aging · doi:10.18632/aging.100861 · Cited by 316
“Ageing researchers and the general public have long been intrigued by centenarians because these subjects managed to avoid, postpone or overcome the major agerelated diseases such as cancer [1], cardiovascular diseases [2], diabetes [3], osteoporotic fractures [4] and dementia [5, 6].”
BackgroundAging in the Natural World: Comparative Data Reveal Similar Mortality Patterns Across Primates
Bronikowski, A. M., Altmann, J., Brockman, D. K., Cords, M., Fedigan, L. M., Pusey, A., Stoinski, T., Morris, W. F., Strier, K. B., & Alberts, S. C. (2011) · Science · doi:10.1126/science.1201571 · Cited by 274
How biological sex of the host shapes its gut microbiota
Valeri, F., & Endres, K. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100912 · Cited by 264
The Genetics of Extreme Longevity: Lessons from the New England Centenarian Study
Sebastiani, P., & Perls, T. T. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00277 · Cited by 207
Self-citationBaumgart, M., Groth, M., Priebe, S., Savino, A., Testa, G., Dix, A., Ripa, R., Spallotta, F., Gaetano, C., Ori, M., et al. (2014) · Aging Cell · doi:10.1111/acel.12257 · Cited by 167
Genetic Signatures of Exceptional Longevity in Humans
Sebastiani, P., Solovieff, N., Puca, A., Hartley, S. W., Melista, E., Andersen, S., Dworkis, D. A., Wilk, J. B., Myers, R. H., Steinberg, M. H., et al. (2010) · Science · doi:10.1126/science.1190532 · Cited by 141
Self-citationRetractedHirata, T., Arai, Y., Yuasa, S., Abe, Y., Takayama, M., Sasaki, T., Kunitomi, A., Inagaki, H., Endo, M., Morinaga, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17636-0 · Cited by 138
The road ahead for health and lifespan interventions
Gonzalez-Freire, M., Diaz-Ruiz, A., Hauser, D., Martinez-Romero, J., Ferrucci, L., Bernier, M., & de Cabo, R. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101037 · Cited by 118
Cancer prevalence and mortality in centenarians: a systematic review
Pavlidis, N., Stanta, G., & Audisio, R. A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.09.007 · Cited by 115
Cumulative Index of Health Deficiencies as a Characteristic of Long Life
Kulminski, A. M., Ukraintseva, S. V., Akushevich, I. V., Arbeev, K. G., & Yashin, A. I. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01155.x · Cited by 96
Genetics of human longevity within an eco-evolutionary nature-nurture framework
Giuliani, C., Garagnani, P., & Franceschi, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.312562 · Cited by 92
Barengo, N. C., Antikainen, R., Borodulin, K., Harald, K., & Jousilahti, P. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14694 · Cited by 87
The extreme longevity: The state of the art in Italy
Franceschi, C., Motta, L., Motta, M., Malaguarnera, M., Capri, M., Vasto, S., Candore, G., & Caruso, C. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2007.06.006 · Cited by 83
Adipokines and Aging: Findings From Centenarians and the Very Old
Arai, Y., Kamide, K., & Hirose, N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00142 · Cited by 71
Transcriptome evidence reveals enhanced autophagy-lysosomal function in centenarians
Xiao, F.-H., Chen, X.-Q., Yu, Q., Ye, Y., Liu, Y.-W., Yan, D., Yang, L.-Q., Chen, G., Lin, R., Yang, L., et al. (2018) · Genome Research · doi:10.1101/gr.220780.117 · Cited by 55
First autopsy study of an Okinawan centenarian: Absence of many age-related diseases
Bernstein, A. M., Willcox, B. J., Tamaki, H., Kunishima, N., Suzuki, M., Craig Willcox, D., Kristen Yoo, J.-S., & Perls, T. T. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.11.1195 · Cited by 56
Self-citationSpecific features of the oldest old from the Longevity Blue Zones in Ikaria and Sardinia
Poulain, M., Herm, A., Errigo, A., Chrysohoou, C., Legrand, R., Passarino, G., Stazi, M. A., Voutekatis, K. G., Gonos, E. S., Franceschi, C., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111543 · Cited by 54
Liu, Y.-W., He, Y.-H., Zhang, Y.-X., Cai, W.-W., Yang, L.-Q., Xu, L.-Y., & Kong, Q.-P. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.023 · Cited by 39
Adams, V. J., Watson, P., Carmichael, S., Gerry, S., Penell, J., & Morgan, D. M. (2015) · Acta Veterinaria Scandinavica · doi:10.1186/s13028-016-0206-7 · Cited by 36
“%) were individuals who delayed the onset of age-associated illness until at least the age of 80 and Escapers (19”
BackgroundAliberti, S. M., Donato, A., Funk, R. H. W., & Capunzo, M. (2024) · Nutrients · doi:10.3390/nu16050729 · Cited by 25
Aliberti, S. M., Funk, R. H. W., Schiavo, L., Giudice, A., Ciaglia, E., Puca, A. A., Gonnella, J., & Capunzo, M. (2022) · Nutrients · doi:10.3390/nu14173665 · Cited by 22
“Based on the previous analysis of the age and clinical evidence of the diseases, the nonagenarians/centenarians fell into three categories, respectively: escapers (had an age of onset of 100 years or had not yet been diagnosed with a disease), survivors (had an age of onset of less than 80 years for at least one of th…”
MethodPrevalence of dementia after age 90: Results from The 90+ Study
Corrada, M. M., Brookmeyer, R., Berlau, D., Paganini-Hill, A., & Kawas, C. H. (2008) · Neurology · doi:10.1212/01.wnl.0000310773.65918.cd · Cited by 11
Metadata
- Authors
- Evert, J., Lawler, E., Bogan, H., & Perls, T.
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-03-01
- Volume
- 58
- Issue
- 3
- Pages
- M232-M237
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2113466108
- Cited by
- 518
- References
- 31
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.